ArticleContraception2018

Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Chelsea B Polis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.